Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 107, Issue 3, Pages 407-415Publisher
WILEY-LISS
DOI: 10.1002/ijc.11411
Keywords
cervical cancer; human papillomavirus; E6; E7; chemokine; monocyte chemoattractant protein-I
Categories
Funding
- NCI NIH HHS [CA53091] Funding Source: Medline
- NIAMS NIH HHS [P30 AR042689] Funding Source: Medline
- NIDCR NIH HHS [R01 DE013178] Funding Source: Medline
Ask authors/readers for more resources
Infection of cervical keratinocytes by high-risk HPV is involved in the etiology of cervical carcinoma. Since viral products are immunogenic, development of cancer may require suppression of immune responses directed against infected epithelial cells. Many markers of host immune effector responses decrease as cervical intraepithelial neoplasia progresses. Among these is epithelial cell expression of the chemokine MCP-I, though the mechanism for its suppression is unclear. Here, we show that the E6 and E7 viral oncogenes from high-risk HPV, individually and together, suppress MCP-I expression in primary epithelial cells derived from the female genital tract. This is not a consequence of global suppression of chemokine expression since other chemokines, including IP-10, IL-8 and RANTES, were less affected. Furthermore, 4 of 6 HPV-positive cervical carcinoma cell lines did not express MCP-I. Our data indicate that suppression of MCP-I expression is part of the program of high-risk HPV E6/E7-induced transformation of primary epithelial cells. These observations are consistent with a model in which MCP-I expression by infected keratinocytes, which would stimulate an immune attack on HPV-transformed cells, is suppressed for invasive cervical cancer to appear. (C) 2003 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available